Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current and future prospects in haemostasis].

J Oldenburg1

  • 1Institut für Experimentelle Hämatologie und Transfusionsmedizin, Universitätsklinik Bonn, Sigmund-Freud-Str. 25, 53105 Bonn. Johannes.Oldenburg@ukb.uni-bonn.de

Hamostaseologie
|January 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren.

Hamostaseologie·2024
Same author

Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis.

Hamostaseologie·2023
Same author

Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders.

Hamostaseologie·2022
Same author

Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts.

ESMO open·2021
Same journal

Diagnosis and Management of Immune Platelet Transfusion Refractoriness.

Hamostaseologie·2026
Same journal

Too Common to Ignore: Decoding the Complexity of the FGG p.Ala108Gly Variant in Fibrinogen Disorders.

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
See all related articles

Advances in genomics and technology are rapidly expanding our understanding of haemostasis. This knowledge fuels the development of targeted therapies and personalized medicine for thromboembolic disorders.

Area of Science:

  • Haemostasis research
  • Genomics and proteomics
  • Thromboembolic disorders

Context:

  • Rapid advancements in human genome sequencing and novel technical tools are significantly enhancing the understanding of haemostasis.
  • This progress facilitates the identification of new genes and the elucidation of complex phenotypes, such as thromboembolic disorders.

Purpose:

  • To explore the expanding knowledge of haemostasis driven by genomic and technological advancements.
  • To investigate the roles of haemostasis proteins in various biological processes and disease states.
  • To highlight the development of novel anticoagulant drugs and personalized therapeutic strategies.

Summary:

  • Current research focuses on identifying novel genes and understanding complex phenotypes like thromboembolic disorders.

Related Experiment Videos

  • Exploration of haemostasis proteins includes crystal structure analysis, protein-protein interactions, and expression profiling.
  • Development of selective anticoagulant drugs is a key outcome, alongside exploring haemostasis protein roles beyond coagulation.

    • Impact:

    • Haemostasis proteins are increasingly recognized for their roles in wound healing, angiogenesis, inflammation, immunity, and tumor growth.
    • Patients stand to benefit from individualized prevention and therapy, including regenerative medicine approaches like stem cell and gene therapy.